current research on cd19 targeted car t-cells in relapsed b-cell all
Published 8 years ago • 242 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:59
efficacy and safety of cd19-targeted car t-cells for relapsed/refractory all
-
1:39
out of specification anti-cd19 car t-cell products in aggressive b-cell lymphomas
-
4:05
risk factors to predict post-cd19 car-t cell therapy outcomes in patients with lbcl
-
1:24
dr. park on using cd19-targeted car t cells as treatment for all
-
2:32
phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
7:19
checkpoint inhibitors augument cd19 car t-cell therapy in relapsed b-all
-
9:33
long-term trial supports cd19-targeted car t cells for relapsed/refractory cll
-
4:47
cd19 car t-cells for adults
-
2:42
dual-targeted anti-cd19/anti-cd20 car t-cells in r/r mcl: insights from a phase i/ii trial
-
2:26
clinical data for cd19-directed car t-cell products in all
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:26
emerging cd19-targeted car-t treatment approaches for nhls
-
4:24
key questions in the field of cd19 car t-cell therapy
-
3:42
factors associated with treatment response to cd19 car t-cell therapy in b-all
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
2:36
cd19- and cd22-directed chimeric antigen receptor t-cell therapy in childhood b-cell all
-
45:46
cd19 targeted car t-cell therapy in lbcl
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy